Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO), announced a strategic addition to its executive team to accelerate its long-term growth objectives, strengthen leadership, and enhance collaboration across the company.

Bob Rodebaugh has been promoted to Vice President of Technology, where he will oversee process and analytical development as well as program management, ensuring customers benefit from a seamless and integrated path throughout the drug development lifecycle. He brings deep CDMO experience and most recently led Gannet BioChem's Huntsville manufacturing operations. Bob holds a PhD in Organic Chemistry from Duke University.

"Expanding our executive team, alongside continued investment in our capabilities — including doubling the capacity of our packaging facilities — positions Gannet BioChem for its next phase of growth," said Nick Shackley, Chief Executive Officer at Gannet BioChem. "By elevating a proven leader into this key role and refining our structure, we are ensuring the company remains agile, efficient, and prepared to meet the evolving needs of our customers and partners in the biopharmaceutical industry."